Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Surgery Partners (SGRY) FCF Margin (2016 - 2025)

Surgery Partners' FCF Margin history spans 12 years, with the latest figure at 10.24% for Q4 2025.

  • For Q4 2025, FCF Margin fell 7.0% year-over-year to 10.24%; the TTM value through Dec 2025 reached 5.91%, down 82.0%, while the annual FY2025 figure was 5.91%, 82.0% down from the prior year.
  • FCF Margin for Q4 2025 was 10.24% at Surgery Partners, up from 7.77% in the prior quarter.
  • Across five years, FCF Margin topped out at 12.71% in Q3 2023 and bottomed at 2.19% in Q4 2022.
  • The 5-year median for FCF Margin is 5.83% (2024), against an average of 4.91%.
  • The largest annual shift saw FCF Margin crashed -4845bps in 2021 before it surged 1072bps in 2023.
  • A 5-year view of FCF Margin shows it stood at 0.92% in 2021, then crashed by -339bps to 2.19% in 2022, then soared by 366bps to 5.82% in 2023, then surged by 77bps to 10.31% in 2024, then decreased by -1bps to 10.24% in 2025.
  • Per Business Quant, the three most recent readings for SGRY's FCF Margin are 10.24% (Q4 2025), 7.77% (Q3 2025), and 7.01% (Q2 2025).